Project Details
TRR 305: Striking a moving target: From mechanisms of metastatic colonization to novel systemic therapies
Subject Area
Medicine
Biology
Biology
Term
since 2021
Website
Homepage
Project identifier
Deutsche Forschungsgemeinschaft (DFG) - Project number 429280966
In Germany, more than 4 million patients live with the diagnosis "cancer". For many of them local disease control could be achieved and they live under the Damocles' sword of pending relapse, i.e. the threat of death from metachronous metastasis. Late distant relapses, however, demonstrate that disseminated cancer cells (DCCs) survive long periods outside the primary tumour and retain the ability to grow and form a metastasis. But what are the mechanisms that are operative during clinical latency periods? What determines whether DCCs remain under control or start to form metastases? Which systemic or organ-specific factors prevent or promote distant relapse after primary treatment and how could therapeutic intervention prevent metachronous metastasis best? The TRR 305 is focusing on these specific questions of the complex metastatic cascade with the goal to pave the way for the development of a new generation of metastasis-preventive therapies. The research programme is structured into two key research areas that reflect the main objectives. Research area A - Cancer cell adaptation to selection forces will focus on cell intrinsic properties functionally linked to the generation of metastasis. It will comprise a framework for the understanding of the sequence of mutational events and thereby define the evolutionary and molecular state of colonising DCCs upon which plasticity is generated. It will then address mechanisms of cancer cell plasticity directly, i.e. how it is generated and how it is regulated. It also includes a technical platform to measure responses of cancer cells to changing microenvironmental conditions and selection forces. Research area B - Immune and niche-dependent conditions of metastatic colonisation focuses on cancer cell interactions with the microenvironment at colony formation. These interactions can either be organ-independent and of general significance or organ-specific determining site-specific metastasis, reflecting the co-adaptation of invading DCCs and niche cells. Also, research area B comprises a technology development project for studying complex cellular interactions by novel in vitro assays. These two research areas built upon each other and thereby will provide ample opportunity and need for interaction and cooperation. Together, they will reciprocally inform about the best and most promising preclinical implementation and enable critical evaluation of clinical targeting chances. These steps will be enabled and promoted by the central Z-platforms.
DFG Programme
CRC/Transregios
Current projects
- A01 - Evolution of systemic cancer: Mapping the acquisition of metastatic traits into cell lineage trees (Project Head Klein, Christoph )
- A02 - From a genomic atlas to a history book of tumour progression and metastatic outgrowth (Project Heads Häberle, Lothar ; Spang, Rainer )
- A03 - Metabolic dysregulations in EMT-driven metastatic colonisation (Project Heads Brabletz, Thomas ; Mougiakakos, Dimitrios )
- A04 - EMT-dependent transcriptional enhancers important for metastatic colonisation (Project Heads Brabletz, Simone ; Schmidl, Christian )
- A05 - Functional analysis of Baz2a containing chromatin remodeling complexes in metastasis models (Project Heads Hosseini, Hedayatollah ; Längst, Gernot M. )
- A06 - The role of non-coding RNAs in metastatic colonisation and microenvironmental adaptation during metronomic therapy (Project Heads Hackl, Christina Elisabeth ; Meister, Gunter )
- A07 - High-throughput screening assays and readouts for targeting metastatic progression (Project Heads Gribbon, Ph.D., Philip ; Honarnejad, Kamran ; Klein, Christoph ; Stojanovic Guzvic, Natasa ; Stutz, Andrea ; Wegener, Joachim )
- B01 - Zeb1 expressing macrophages control metastatic colonisation (Project Head Brabletz, Thomas )
- B02 - Modulating the tumor metastasis propagating and inhibiting effects of tumor associated macrophages via Fc-receptors (Project Head Nimmerjahn, Falk )
- B03 - Organ defense during metastatic colonization by shielding macrophages (Project Heads Krönke, Gerhard ; Pukrop, Tobias )
- B05 - The role of dendritic cells in metastatic colonization and immunosurveillance of melanoma (Project Head Dudziak, Diana )
- B06 - Functional role of fibroblast reticular cell-derived IL-33 in early metastasis (Project Heads Feuerer, Markus ; Hehlgans, Thomas )
- B07 - The role of the EMT-transcription factor Zeb1 in CAFs for metastatic colonisation and growth (Project Heads Britzen-Laurent, Nathalie ; Stemmler, Marc )
- B08 - Angiocrine signaling in metastatic colonisation of colon cancer (Project Heads Günther, Claudia ; Naschberger, Elisabeth )
- B09 - Disseminated cancer cell-derived extracellular vesicles in early metastatic organ colonisation (Project Head Werner-Klein, Melanie )
- B11 - Steatosis associated soiI factors of the liver metastatic niche (Project Head Hellerbrand, Claus )
- B12 - Characterization of neuropeptide-receptor cross-talk driving metastatic liver colonization by disseminated cancer cells (Project Heads Bosserhoff, Anja-Katrin ; Dietrich, Ph.D., Peter )
- B13 - Novel patient-specific immune competent preclinical in vitro models to study early metastasis (Project Heads Braun, Armin ; Sonntag, Frank ; Werno, Christian )
- Z01 - Data management, Bioinformatics and Imaging Platform (Project Heads Bäuerle, Tobias ; Ferrazzi, Fulvia ; Spang, Rainer ; Wittenberg, Thomas )
- Z02 - Service platform for tracking cancer from early spread at diagnosis to multi-organ manifestation (Project Heads Evert, Katja ; Fasching, Peter ; Hartmann, Arndt ; Klein, Christoph )
- Z03 - Serviceprojekt (Project Head Klein, Christoph )
Applicant Institution
Universität Regensburg
Co-Applicant Institution
Friedrich-Alexander-Universität Erlangen-Nürnberg
Participating Institution
Fraunhofer-Institut für Integrierte Schaltungen (IIS)
Abteilung Bildverarbeitung und Medizintechnik (aufgelöst); Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP
Drug Discovery Research ScreeningPort; Fraunhofer-Institut für Toxikologie und Experimentelle Medizin (ITEM)
Fraunhofer-Projektgruppe Regensburg
Forschungsbereich Personalisierte Tumortherapie; Fraunhofer-Institut für Toxikologie und Experimentelle Medizin (ITEM); Fraunhofer-Institut für Werkstoff- und Strahltechnik (IWS); Universität Regensburg
Fakultät für Chemie und Pharmazie
Institut für Analytische Chemie, Chemo- und Biosensorik
Abteilung Bildverarbeitung und Medizintechnik (aufgelöst); Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP
Drug Discovery Research ScreeningPort; Fraunhofer-Institut für Toxikologie und Experimentelle Medizin (ITEM)
Fraunhofer-Projektgruppe Regensburg
Forschungsbereich Personalisierte Tumortherapie; Fraunhofer-Institut für Toxikologie und Experimentelle Medizin (ITEM); Fraunhofer-Institut für Werkstoff- und Strahltechnik (IWS); Universität Regensburg
Fakultät für Chemie und Pharmazie
Institut für Analytische Chemie, Chemo- und Biosensorik
Spokesperson
Professor Dr. Christoph Klein